Financials
- Market Capitalization 976.97 M
- Employee 108
- Founded 2017
- CEO N/A
- Website www.januxrx.com
- Headquarter Delaware, United States
- FIGI BBG00ZHSKH11
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.54
Relación precio/flujo de caja
85.51
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2462 | SANA Sana Biotechnology, Inc. - Common Stock | 3.65 USD | +0.27% | -8.06% | +32.73% | -13.51% | 1.02 B USD | ||
| 2478 | VOR Vor Biopharma Inc. - Common Stock | 18.25 USD | +1.22% | -8.20% | +23.73% | +39.31% | 988.89 M USD | ||
| 2483 | AVTX Avalo Therapeutics, Inc. - Common Stock | 18.69 USD | -1.16% | -4.10% | +24.52% | +280.65% | 982.45 M USD | ||
| 2486 | KURA Kura Oncology, Inc. - Common Stock | 11.04 USD | +1.19% | -3.92% | +20.26% | +72.77% | 980.07 M USD |